Recommended Antibiotics for Uncomplicated UTI
For uncomplicated cystitis in women, nitrofurantoin for 5 days is the preferred first-line agent, with fosfomycin (single dose), trimethoprim (3 days), or trimethoprim-sulfamethoxazole (3 days) as alternatives when local resistance rates are <10-20%. 1, 2
First-Line Agents for Uncomplicated Cystitis
The following antibiotics are recommended based on their efficacy, safety profile, and ability to minimize collateral damage and resistance 1, 2, 3:
- Nitrofurantoin: 100 mg twice daily for 5 days
- Fosfomycin: 3 grams as a single oral dose
- Trimethoprim: 100 mg twice daily for 3 days
- Trimethoprim-sulfamethoxazole (TMP-SMX): 160/800 mg twice daily for 3 days
Critical caveat: TMP-SMX and trimethoprim should only be used when local resistance rates are <20% 4, 5. Fluoroquinolones are NOT first-line options due to safety concerns and rising resistance rates 5.
Uncomplicated Pyelonephritis
For outpatient oral treatment of uncomplicated pyelonephritis, fluoroquinolones and cephalosporins are the only recommended agents 6:
Oral Regimens:
- Ciprofloxacin: 500-750 mg twice daily for 7 days (only if fluoroquinolone resistance <10%)
- Levofloxacin: 750 mg once daily for 5 days (only if fluoroquinolone resistance <10%)
- Cefpodoxime: 200 mg twice daily for 10 days
- Ceftibuten: 400 mg once daily for 10 days
- TMP-SMX: 160/800 mg twice daily for 14 days (if susceptible)
Important: When using oral cephalosporins empirically, administer an initial IV dose of long-acting parenteral antimicrobial (e.g., ceftriaxone 1-2g) first 6.
Parenteral Regimens (for hospitalized patients):
- Ceftriaxone: 1-2 g once daily (preferred empiric choice)
- Ciprofloxacin: 400 mg twice daily IV
- Levofloxacin: 750 mg once daily IV
- Gentamicin: 5 mg/kg once daily (with or without ampicillin)
Avoid nitrofurantoin, fosfomycin, and pivmecillinam for pyelonephritis—insufficient efficacy data 6.
Special Populations
Pregnancy
Beta-lactams, nitrofurantoin, fosfomycin, and TMP-SMX can be appropriate treatments 4. However, avoid TMP-SMX in the first trimester (folate antagonism risk) and avoid nitrofurantoin near term (hemolytic anemia risk in newborns).
Renal Impairment
Avoid nitrofurantoin when creatinine clearance <30 mL/min—inadequate urinary concentrations and increased risk of toxicity. Adjust aminoglycoside and beta-lactam dosing based on renal function.
Men with UTI
Men should always receive antibiotics with urine culture guiding therapy 2. First-line agents include:
- Trimethoprim: 100 mg twice daily for 7 days
- TMP-SMX: 160/800 mg twice daily for 7 days
- Nitrofurantoin: 100 mg twice daily for 7 days
Consider urethritis and prostatitis in the differential—these require longer treatment courses (2-4 weeks) 2.
Older Adults (≥65 years)
Treatment regimens and durations are the same as younger adults 2. However, always obtain urine culture with susceptibility testing to adjust empiric therapy, as resistance patterns may differ.
Resistance Considerations
Risk factors for antimicrobial resistance that should guide empirical selection 5:
- Recent antimicrobial use (within 3 months)
- History of resistant isolates
- Healthcare-associated infections
- Recent hospitalization or instrumentation
- Travel to high-resistance areas
- Diabetes mellitus
- Immunosuppression
When these factors are present, consider broader-spectrum agents or obtain culture before treatment.
Treatment Duration Summary
The evidence supports shorter courses for uncomplicated cystitis 1:
- Nitrofurantoin: 5 days (clear recommendation)
- Fosfomycin: Single dose (clear recommendation)
- Fluoroquinolones: 3 days (clear recommendation)
- TMP-SMX: 3 days (clear recommendation)
- Pivmecillinam: 3 days (clear recommendation)
For pyelonephritis 6:
- Beta-lactams: 7 days
- Fluoroquinolones: 5-7 days
Common Pitfalls to Avoid
Do not treat asymptomatic bacteriuria (except in pregnancy or before urologic procedures)—this drives unnecessary antibiotic use and resistance 4
Do not use fluoroquinolones as first-line for cystitis—reserve for pyelonephritis or when first-line agents fail 5
Do not rely on dipstick alone in high-probability cases—negative dipstick does not rule out UTI when symptoms are classic 4
Do not use broad-spectrum agents empirically unless risk factors for multidrug-resistant organisms are present 6
Carbapenems and novel agents should only be used when early culture results indicate multidrug-resistant organisms 6